Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 48, 2009, Pages 20365-20370

  Greenbaum, Jason A ^a   Kotturi, Maya F ^a   Kim, Yohan ^a   Oseroff, Carla ^a   Vaughan, Kerrie ^a   Salimi, Nima ^a   Vita, Randi ^a   Ponomarenko, Julia ^b   Scheuermann, Richard H ^c   Sette, Alessandro ^a   Peters, Bjoern ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Databases; Epitopes; Meta analysis; Pandemic

Indexed keywords

B LYMPHOCYTE ANTIBODY; EPITOPE; HEMAGGLUTININ; MEMBRANE PROTEIN; SIALIDASE; T LYMPHOCYTE ANTIBODY; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; ANTIGEN RECOGNITION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DATA BASE; DISEASE SEVERITY; EPITOPE MAPPING; IMMUNOLOGICAL MEMORY; INFLUENZA VIRUS A H1N1; MEMORY T LYMPHOCYTE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; SWINE INFLUENZA VIRUS; T LYMPHOCYTE; VIRUS STRAIN;

CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COMPUTATIONAL BIOLOGY; CROSS PROTECTION; DATABASES, GENETIC; EPITOPES; HEMAGGLUTININS; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS, H1N1 SUBTYPE; MODELS, MOLECULAR; NEURAMINIDASE;

ORTHOMYXOVIRIDAE; SUIDAE;

EID: 73949102909     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0911580106     Document Type: Article

References (27)

1. Cohen J, Enserink M (2009) Swine flu. After delays, WHO agrees: The 2009 pandemic has begun. Science 324:1496-1497.
2. Garten RJ, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197-201.
3. Itoh Y, et al. (2009) In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature, in press.
4. Centers for Disease Control and Prevention (2009) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR 58:521-524.
5. Munster VJ, et al. (2009) Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325:481-483.
6. Maines TR, et al. (2009) Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325:484-487.
7. Bui HH, Peters B, Assarsson E, Mbawuike I, Sette A (2007) Ab and T-cell epitopes of influenza A virus, knowledge and opportunities. Proc Natl Acad Sci USA 104:246-251.
8. Peters B, et al. (2005) The immune epitope database and analysis resource: From vision to blueprint. PLoS Biol 3:e91.
9. Bao Y, et al. (2008) The influenza virus resource at the National Center for Biotechnology Information. J Virol 82:596-601.
10. Bogner P, Capua I, Lipman DJ, Cox NJ, et al. (2006) A global initiative on sharing avian flu data. Nature 442:981.
11. Nguyen HH, et al. (2007) Heterosubtypic immunity to influenza A virus infection requires a properly diversified antibody repertoire. J Virol 81:9331-9338.
12. Couch RB (2003) An overview of serum antibody responses to influenza virus antigens. Dev Biol (Basel) 115:25-30.
13. Prabhu N, et al. (2009) Monoclonal antibodies against the fusion peptide of hemagglutinin protect mice from lethal influenza A virus H5N1 infection. J Virol 83:2553-2562.
14. Liew FY, Russell SM, Appleyard G, Brand CM, Beale J (1984) Cross-protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T-cell reactivity. Eur J Immunol 14:350-356.
15. TerajimaM, et al. (2008) Influenza A virus matrix protein 1-specific human CD8+T-cell response induced in trivalent inactivated vaccine recipients. J Virol 82:9283-9287.
16. McMichael AJ, Gotch FM, Noble GR, Beare PA (1983) Cytotoxic T-cell immunity to influenza. N Engl J Med 309:13-17.
17. Webby RJ, et al. (2003) Protection and compensation in the influenza virus-specific CD8+ T-cell response. Proc Natl Acad Sci USA 100:7235-7240.
18. McElhaney JE, et al. (2006) T-cell responses are better correlates of vaccine protection in the elderly. J Immunol 176:6333-6339.
19. Bender BS, Croghan T, Zhang L, Small PA, Jr. (1992) Transgenic mice lacking class Imajor histocompatibility complex-restricted T cells have delayed viral clearance and increased mortality after influenza virus challenge. J Exp Med 175:1143-1145.
20. Basler CF, et al. (2001) Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc Natl Acad Sci USA 98:2746-2751.
21. Stevens J, et al. (2006) Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312:404-410.
22. Yen HL, et al. (2009) Changes in H5N1 influenza virus hemagglutinin receptor binding domain affect systemic spread. Proc Natl Acad Sci USA 106:286-291.
23. Garcia-Sastre A, et al. (1998) Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252:324-330.
24. Kreijtz JH, et al. (2008) Cross-recognition of avian H5N1 influenza virus by human cytotoxic T-lymphocyte populations directed to human influenza A virus. J Virol 82:5161-5166.
25. Lee LY, et al. (2008) Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 118:3478-3490.
26. Schwede T, Kopp J, Guex N, Peitsch MC (2003) SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res 31:3381-3385.
27. Oseroff C, et al. (2005) HLA class I-restricted responses to vaccinia recognize a broad array of proteins mainly involved in virulence and viral gene regulation. Proc Natl Acad Sci USA 102:13980-13985.